WHO ICTRP trial
A randomized controlled clinical study on the treatment of refractory immune…
ChiCTR-IOR-16010001 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-IOR-16010001 |
|---|---|
| Public title | A randomized controlled clinical study on the treatment of refractory immune thrombocytopenia with the combination of Sheng Ling and small dose of hormone |
| Scientific title | A randomized controlled clinical study on the treatment of refractory immune thrombocytopenia with the combination of Sheng Ling and small dose of hormone |
| Primary sponsor | Shanghai University of Traditional Chinese Medicine affiliated Yueyang Hospital of traditional Chinese and Western Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | Other |
| Countries | China |
| Conditions | Refractory immune thrombocytopenia syndrome |
| Interventions | experimental group:Blood spirit of traditional Chinese medicine (Shen Qi Qi Sheng Qi Sheng Xue mixture) combined with small dose of hormone;Control group:Oral prednisone tablets 20mg once, after breakfast, once every two days. |
| Registration date | Nov 24, 2016 |
| Target size | experimental group:90;Control group:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: